Detalhe da pesquisa
1.
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Nature
; 620(7973): 409-416, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532934
2.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Lancet
; 403(10421): 31-43, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048793
3.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
N Engl J Med
; 386(5): 437-448, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045221
4.
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Int J Cancer
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676430
5.
Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Histopathology
; 84(2): 291-300, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771077
6.
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer.
Int J Gynecol Cancer
; 34(4): 469-477, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101816
7.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129136
8.
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.
Lancet Oncol
; 24(8): 892-902, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429302
9.
Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection.
Oncologist
; 28(7): 633-639, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971503
10.
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients.
Curr Opin Oncol
; 35(4): 288-291, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222199
11.
The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features.
Mod Pathol
; 36(10): 100243, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307879
12.
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
J Transl Med
; 21(1): 408, 2023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353806
13.
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.
Gynecol Oncol
; 173: 98-105, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105063
14.
Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
Gynecol Oncol
; 174: 190-199, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210929
15.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
16.
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy.
J Natl Compr Canc Netw
; 21(5): 473-479.e4, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156482
17.
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.
J Immunol
; 206(10): 2265-2270, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931486
18.
NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancer.
Future Oncol
; 19(25): 1715-1727, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650734
19.
Splenectomy in epithelial ovarian cancer surgery.
Int J Gynecol Cancer
; 33(6): 944-950, 2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948526
20.
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?
Int J Gynecol Cancer
; 33(11): 1675-1681, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640446